Delivery Order SPE2DB20D1100-SPE2DB25FC6D0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp on September 26, 2025, for supply of Ojjaara 200 mg tablets in 30-count units. This firm fixed price contract, with an ultimate completion date of October 20, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery order was competitively awarded with no...
- The Defense Logistics Agency has awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for the supply of Ojjaara 200 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ojjaara 200 mg tablets in 30-count packaging. This firm fixed-price delivery order, valued at $17,849.85, represents a non-competitive, non-set-aside award to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for 200 mg Ojjaara tablets in quantities of 30 units, with an ultimate completion date of July 7, 2025. This firm fixed-price delivery order, issued on June 12, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $17,849.85 on September 9, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a non-set-aside, competitively awarded contract supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ojjaara 200 mg tablets in packages of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $17,849.85 with firm fixed pricing and is scheduled for completion by September 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same municipality....
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Ojjaara 100 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $17,912.32, is scheduled for completion by July 9, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, competitive delivery order placement under an existing contract...
- The Defense Logistics Agency (DLA) awarded a $17,849.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30 units. The contract, which represents a child award under AmerisourceBergen's larger IDC with DLA, is scheduled for completion by August 25, 2025. The award was made on a competitive basis with no set-aside designation, and the pharmaceutical products will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a $17,849.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets (30-count units) with an ultimate completion date of June 24, 2025. This non-set-aside competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count units, with a completion date of September 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC6D0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for supply of Ojjaara 200 mg tablets in 30-count units. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with performance completion targeted for June 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will execute this delivery order under a broader Indefinite Delivery Contract with the DLA Troop Support Medical division. This delivery order represents a routine pharmaceutical procurement transaction within AmerisourceBergen's extensive federal supply relationship with the Defense Logistics Agency. As a major pharmaceutical distributor serving federal medical procurement needs, the company maintains a $999.99 billion indefinite delivery contract with DLA Troop Support Medical (SPE2DX) through December 2026, which supports military healthcare systems globally. This delivery order for Ojjaara demonstrates the company's capability to supply specialty medications across multiple therapeutic domains to support Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 5/30/25 |